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Summary  Psychological factors and the autonomic nervous system (ANS) are 
implicated in the pathogenesis of inflammatory bowel diseases (IBD) and irritable bowel 
syndrome (IBS). This study aimed to assess, firstly the way IBS and IBD patients cope with 
their pathology according to their affective adjustment and secondly the possible links 
between these affective adjustments and ANS reactivity. Patients with Crohn’s disease (CD; 
n=26), ulcerative colitis (UC; n=22), or IBS (n=27) were recruited and compared to 21 
healthy subjects based on psychological variables (trait- and state anxiety, depressive 
symptomatology, negative mood, perceived stress, coping, health locus of control) and 
sympatho-vagal balance through heart-rate variability monitored at rest. A principal 
component analysis, performed on all affective variables, isolated a leading factor labelled as 
“affective adjustment”. In each disease, patients were distributed into positive and negative 
affective adjustment. In all the diseases, a positive affect was associated with problem-
focused coping, and a negative affect with emotion-focused coping and external health locus 
of control. Results show that the sympatho-vagal balance varied according to the disease. In 
CD presenting positive affectivity, an adapted high sympathetic activity was observed. In UC, 
a parasympathetic blunt was observed in the presence of negative affectivity and an 
equilibrated sympatho-vagal balance in the presence of positive affectivity. In contrast, in 
IBS, an important dysautonomia (with high sympathetic and low parasympathetic tone) was 
constantly observed whatever the affective adjustment. In conclusion, this study suggests that 
the equilibrium of the ANS is differentially adapted according to the disease. This equilibrium 
is conjugated with positive affective and cognitive adjustment in IBD (CD and UC) but not in 
IBS.  
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1. Introduction 
Inflammatory bowel diseases (IBD) are primarily comprised of  2 disorders: ulcerative colitis 
(UC) and Crohn’s disease (CD). IBD are characterized by a chronic course in which phases of 
remission of variable length are interrupted by acute episodes. Irritable Bowel Syndrome 
(IBS) is a highly prevalent functional gastrointestinal disorder mainly characterized by 
abdominal pain and discomfort in association with altered bowel habits in the absence of any 
structural abnormalities (Schepper et al., 2008; Thompson et al., 2000; Thompson et al., 
1999). Despite differences in the aetiologies of IBD and IBS (Baumgart and Sandborn, 2007; 
Von Stein et al., 2008) stress represents a common risk factor in their pathogenesis. Patients 
often report stressful life events at the onset and/or during the time course of their disease 
(Collins, 2001; Li et al., 2004; Mawdsley and Rampton, 2005; Mönnikes et al., 2001; Reber et 
al., 2006; Tang et al., 2008). The burden of such chronic diseases adds undercurrents of 
psychological strain to the weight of the pathology. Most of the psychological disturbances 
reported in IBD and IBS are therefore principally related to the illness’ time course (Jones et 
al., 2006). It results in high perceived stress levels (Rogala et al., 2008; Tang et al., 2008), 
impaired quality of life (Coffin et al., 2004) and affective co-morbidities such as worries, 
anxiety, negative mood or depression (Miehsler et al., 2008; Mittermaier et al., 2004; Olden, 
2008; Sugaya and Nomura, 2008). This forces the patients to develop coping strategies such 
as i) problem-focused coping (i.e., where the individual faces the problem, seeks a solution, 
tries to resolve it), ii) emotion-focused coping (i.e., where the individual changes by denying 
that there is a problem to be able to cope with) and iii) search for social support (i.e., where 
the individual asks his family or health professionals for help, or counselling). These coping 
strategies may in turn influence the path of their disease: CD patients with low avoidance 
coping strategies were the least likely to relapse (Bitton et al., 2008). The individual coping 
style may therefore determine the outcome, which combines psychological (e.g., anxiety, 
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depression), social (e.g., absenteeism, social withdrawal) and biological (e.g., evolution of the 
disease) dimensions. This is commonly observed in multiple chronic diseases (such as 
arthritis or heart disease) in which problem-focused coping or search for social support is 
usually more beneficial than emotion-focused coping (Martz and Livneh, 2007; Thompson 
and Gustafson, 1996). This point of view agrees with the Lazarus & Folkman’s transactional 
model of stress in which stress is considered as the result of an “imbalance between demands 
and resources” occurring when “pressure exceeds one's perceived ability to cope” (Lazarus 
and Folkman, 1984). It could be speculation then, that the extent of positive affects influence 
coping in favour of beneficial ways (i.e. problem-focused and social search coping). 
The interrelations between digestive diseases and psychological disturbances reflect 
the special link between the brain and the gut in what is called the “brain-gut axis”. The 
autonomic nervous system (ANS) is the neural interface relaying bottom-up and top-down 
informations. Visceral sensations are carried through vagal afferents. These informations 
directly modulate efferent premotor regions of the ANS (Craig, 2002; Mayer et al., 2006). 
More importantly, these efferent regions can also be negatively or positively modulated by a 
set of upper brain regions like amygdala, hippocampus and prefrontal cortex (Benarroch, 
1993; Loewy and Spyer, 1990; Saper, 2002). These regions which can modulate gut function, 
are also involved in the regulation of emotional (e.g., mood, anxiety, negative affects, pain) 
and cognitive behaviours (e.g., decision making, planning, search for informations), and 
therefore in the development of social behaviour, coping strategy and well-being (Gillanders 
et al., 2008; Seminowicz et al., 2004). Accordingly, a growing body of evidence suggests the 
existence of autonomic dysfunctions in patients with IBD and IBS (Ollsson et al., 2007; 
Spaziani et al., 2008; Spetalen et al., 2008; Taylor and Keely, 2007; Van Orshoven et al., 
2006), whatever the severity of symptoms and even during remission in IBD or asymptomatic 
phase in IBS (Ganguli et al., 2007; Sharma et al., 2008). Despite these findings, little is 
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known about the type of autonomic dysfunctions according to the way patients are 
psychologically adjusted with negative or positive affects. We speculate that the positive or 
negative affects observed in IBD and IBS patients are associated to specific coping strategies 
(more problem-centred in the positive affects cases or more emotion-centred in the negative 
affects cases) and to an adapted ANS activity (equilibrated autonomic balance in the positive 
affects cases and an imbalance in the negative affects cases). Since gut diseases are 
heterogeneous, we have studied these relations in three groups of patients (IBS, IBD with CD 
or IBD with UC) in comparison to healthy controls. In order to understand the links between 
emotional affects, coping strategies and ANS adaptations, each group of patients was 
subdivided into two subgroups according to their emotional adjustment. Differences in coping 
style and ANS balance were analyzed in these two subgroups. 
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2. Materials and Methods 
2.1. Subjects (Table 1, subject demographics) 
Ninety-six subjects were prospectively recruited between January 1st, 2006 and December 
31st, 2007. All patients were recruited in our Gastroenterology Department while age- and 
sex-matched healthy subjects were included from the Grenoble Inserm Clinical Investigation 
Centre. Subjects were distributed as: i) Healthy volunteers (controls, n=21), ii) IBS patients 
(n=27), iii) IBD patients (UC, n=22; CD, n=26). The study was conducted according to the 
Declaration of Helsinki and in accordance with the guidelines of Good Clinical Practice. The 
protocol was approved by the ethical committee of the Grenoble Faculty of Medicine and 
Hospital (France) and written informed consent was obtained from each participant. 
2.2. Criteria for inclusion 
2.2.1. IBD patients 
CD patients were selected according to their phenotype as defined by the Vienna 
classification (Gasche, 1998). CD patients with isolated ano-perineal or upper digestive tract 
lesions were not eligible. CD activity was evaluated by the Harvey–Bradshaw index (HBI, 
(Harvey and Bradshaw, 1980) and patients with an HBI>4 on inclusion were considered 
under clinical relapse. UC patients with lesions limited to the rectum were not eligible. UC 
activity was evaluated by the ulcerative colitis activity index (UCAI; Lichtiger et al., 1994) 
and patients with a UCAI≥10 were considered to have a clinical relapse. 
Concomitant treatments (e.g., date of start, duration, stable dose, mean dose) were 
recorded. Patients were included only if they had a stable dose of i) 5-aminosalicylates for at 
least 2 weeks, ii) corticosteroids for at least 2 weeks, iii) immunosuppressives (e.g., 
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azathioprine/mercaptopurine, methotrexate) for at least 12 weeks, and iv) biological therapy 
(e.g., infliximab, adalimumab) for at least 8 weeks. 
2.2.2. IBS patients  
Patients were selected according to Rome II criteria (Thompson et al., 1999): at least 12 
weeks, not necessarily consecutive, in the preceding 12 months of abdominal discomfort or 
pain that has two out of three features: 1) Relieved with defecation; and/or 2) Onset associated 
with a change in frequency of stool; and/or 3) Onset associated with a change in form 
(appearance) of stool. Patients who had previously undergone abdominal surgery, except 
appendectomy and/or cholecystectomy, were excluded from the study. The severity of disease 
was estimated through the completed standardized bowel disease questionnaire (Coffin et al., 
2004) and a visual analogic scale (VAS) measuring the intensity of perceived pain the day of 
HRV assessment. The lack of organicity for patient’s symptoms was assumed through: i) a 
negative physical examination; ii) a normal colonoscopy performed within the last five years 
with normal biopsies (i.e., absence of microscopic colitis); iii) normal limited laboratory 
evaluations with a lack of inflammation (i.e., erythrocyte sedimentation rate, C-reactive 
protein), anaemia and infection (complete blood cell count) and endocrine or metabolic 
disturbances (i.e., thyroid stimulating hormone, chemical analysis). 
2.3. Criteria for exclusion 
Patients were excluded from the study if: (i) they did not fulfil the regulatory conditions; (ii) 
they had past or present medical conditions complicated by autonomic dysfunction (e.g., 
peripheral neuropathy, diabetes, vagotomy, dysthyroidism, amyloidosis, asthma, heart failure, 
renal insufficiency, alcoholism), psychiatric disorders (e.g., panic disorder, uncontrolled 
depression), (iii) they were under medication susceptible to modify the ANS (e.g., 
anticholinergics, antiarrhytmics, clonidine, beta blocking agents, tricyclic antidepressants, 
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metronidazole). Smokers were asked to abstain from smoking on the morning of their testing 
session. 
 
2.4. Experimental design 
All patients underwent an interview concerning their history (disease duration, extent, extra-
intestinal manifestations, course, current and past therapies, past medical history, 
medications) and a physical examination in order to determine their inclusion in the study 
according to the defined criteria described above. 
After enrolment, the patients came one at a time in the Department of 
Gastroenterology. Upon their arrival, patients were led into a quiet examining room and asked 
to sit down in a comfortable armchair. After a 30-min period of relaxation, patients underwent 
a 10-min ECG assessment during which the technician carefully observed the optimal 
condition to ensure that recording was free of body movements, conversations, and any 
subjective discomfort. After ECG recording, patients responded to psychological 
questionnaires in a separate quiet examining room for 30 to 45 min. All experimental sessions 
were performed between 8 AM and 12 AM. 
2.5. Autonomic assessment: Power spectral analysis of Heart Rate 
Variability 
ANS activity was explored using heart rate variability (HRV) as a reliable and non invasive 
method to assess sympatho-vagal balance (Lombardi et al., 1996). Initially described by 
Akselrod (Akselrod et al., 1981) to explore cardiovascular control, this tool is now commonly 
used in gastrointestinal physiology to assess autonomic imbalances related to digestive 
autonomic regulation (Chen et al., 2004; Chen et al., 2006; Jarrett et al., 2008; Ng et al., 2007; 
Petelenz et al., 2004). ECG signal was acquired through electrodes placed on each wrist. HRV 
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analysis was performed with specific software (Heart Rhythm Scanner, Biocom 
Technologies, USA). Firstly, QRS complexes were automatically classified. Ectopic or 
abnormal QRS complexes and noise were automatically removed. The signal was then 
carefully checked and remaining abnormalities were manually removed. Then, a standard 
spectral analysis was applied on inter-beat intervals by means of Fast Fourier Transformation 
(FFT). The following parameters were calculated: (i) Total Power (TP, from 0 to 0.4 Hz, 
msec2) was considered as the net effect of all physiological mechanisms contributing to HRV; 
(ii) High Frequency power spectrum (HF, from 0.15 to 0.4 Hz, msec2) reflected both 
parasympathetic and fluctuations caused by respiratory sinus arrhythmia; (iii) Low Frequency 
power spectrum (LF, from 0.04 to 0.15 Hz, msec2) reflected both sympathetic and 
parasympathetic tone; (iv) Very Low Frequency power spectrum (VLF, from 0.0033 to 
0.004 Hz, msec2) might represent various negative emotions or worries in short time 
recording (Yeragani et al., 1998). These variables were then expressed in normalized units: 
normalized VLF (VLFn) was calculated as the ratio of absolute values VLF/TP-(LF+HF) and 
the same was carried out for normalized HF [HFn, HF/(TP-VLF)] and normalized LF [LFn, 
LF/(TP-VLF)]. This calculation minimized the effect of changes in Very Low Frequency 
power or LF and HF power and emphasized the changes in sympathetic or parasympathetic 
regulation. (v) Lastly, LF/HF ratio was calculated as a global marker of the balance between 
sympathetic and parasympathetic tones. 
2.6. Psychological assessments 
Anxious symptomatology was assessed using the trait version of the State-Trait Anxiety 
Inventory (STAI; Spielberger et al., 1983), validated in French by Bruchon-Schweitzer and 
Paulhan (Bruchon-Schweitzer and Paulhan, 1993). It differentiates the more general and long-
standing quality of “trait anxiety” from the temporary condition of “state anxiety”. It consists 
of two scales with 20 items each, with a score varying from 20 to 80, a high score indicating 
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high anxiety. In the present sample, the internal consistency was high in both scales (state-
anxiety scale: alpha=0.93; trait-anxiety scale: alpha=0.90).  
Depressive symptomatology was assessed by the Center for Epidemiologic Studies-
Depression Scale (CES-D; (Fuhrer and Rouillon, 1989; Radloff, 1977). This brief scale (20 
items) assesses symptoms or behaviours often associated with depression. The total score 
varies from 0 to 60, a high score signifying a high level of depressive symptomatology. An 
alpha coefficient for internal consistency of 0.85 has been reported in general population 
samples and 0.90 in psychiatric samples (Nunnally, 1978). In the present sample, the alpha 
coefficient was 0.92. 
Perceived stress was evaluated by the Perceived Stress Scale (PSS; (Cohen, 1983), which 
corresponds to the transactional definition of stress proposed by Lazarus et Folkman where a 
situation is perceived as stressful if it is perceived as threatening, unpredictable and 
uncontrollable (Lazarus and Folkman, 1984). This 14-items PSS version presents the best 
psychometric qualities. Each item is coded for the preceding one-month period from 1 
« never » to 5 « often ». A global stress intensity score is calculated from 14 to 70, a high 
score signifying high stress intensity. In the present sample, the alpha coefficient was 0.80. 
Negative mood was assessed with the negative mood subscale of the Positive And Negative 
Affect Scale (PANAS; (Watson et al., 1988a). The response of clinical or normal subjects on 
pleasant and unpleasant emotional content followed a 2-factor structure with pleasant terms 
(e.g., being enthusiastic, active) called “positive affect” and unpleasant terms (e.g., sadness, 
distress, hostility, worry) called “negative affect”. The latter, often considered as a general 
indicator of psychological distress, is composed of depression, anxiety and neurosis. The 
balance between both factors is evaluated through 20 emotional states (10 positive and 10 
negative). For each state, the patients indicate how they felt during the last month on a 5-point 
Lickert scale (from « not at all » to « very often »). The score for negative affect vary from 10 
S. Pellissier et al. Psychological and autonomic dysfunctions in IBD and IBS 
 
12 
to 50, a high score meaning a high negative affect. In the present sample, the alpha coefficient 
was 0.82 for the negative affect scale. 
Coping strategies were measured by the Ways of Coping Checklist Revised (WCC-R; 
(Vitaliano et al., 1985), validated in French by Cousson et al. (Cousson et al., 1996). The 
questionnaire is composed of three subscales: (i) problem-focused coping with a total score 
varying from 10 to 40 (ii) emotion-focused coping (total score from 9 to 36) and (iii) 
searching social support (total score from8 to 32). For each subscale, a high score indicates a 
tendency to use the coping strategy. In our sample, the internal consistency for each subscale 
was 0.79, 0.45, and 0.85, respectively. 
Health locus of control was evaluated with the Multidimensional Health Locus of Control 
Scale (MHLCS; (Wallston et al., 1978). It provides assessments of internal self-perceived 
(one scale) and external perceived locus of control (2 scales, “powerful others” indicates the 
responsibility for the individual’s health on healthcare or professionals; and “Chance” 
indicates that health is under the control of fate or luck). Respondents were asked to answer 
on a 6-point Lickert scale from « strong disagreement » to « strong agreement ». The total 
score for each scale varies from 4 to 24. A high score on the internal scale indicates personal 
health responsibility and high scores on both external scales indicate no personal health 
responsibility. In our sample, the internal consistency was 0.45 for internal subscale, 0.67 for 
“powerful others”, and 0.40 for “chance” subscales. 
2.7. Statistical analysis  
A Principal Components Analysis was first performed to detect a relationship between 
affective variables (i.e., CES-D, PANAS negative mood, STAI, PSS) and to reduce them into 
a single robust dimensional axis. The results of an exploratory factor analysis support such as 
a single-factor solution explaining 73.9% of the variance. For instance, subjects with low 
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affective tonus exhibited high scores in STAI, CES-D, PANAS negative mood, and PSS. All 
variables had a negative weight on this factor meaning that subjects with low scores on this 
new variable presented a positive affect and subjects with high scores had a negative affect. 
Factor scores were then used to categorize subjects in negative or positive affect using K-
means clustering method based on observations. Two clusters of subjects (Table 2) were 
therefore identified: subjects with positive affect (CD+, UC+ and IBS+ patients) and subjects 
with negative affect (CD-, UC- and IBS- patients). 
A complementary analysis was carried out to determine whether the actual activity of 
the disease, as assessed through disease activity index, in IBD patients or the level of 
perceived pain in IBS patients, modified acutely both psychological and physiological states, 
in order to verify if the level of disease activity constituted a bias. No interactions between 
disease activity variables and variables of interest were observed for UC and IBS patients. In 
contrast, an interaction between disease activity index and affective adjustment was found for 
HRV variables for CD patients. Patients with active CD were therefore discarded from the 
following steps of statistical analysis (n=5 patients). Moreover, concerning IBS patients, half 
of them reported diarrhoea but they were equally distributed in both negative and positive 
affective adjustment groups (Chi2 = 1,05; dl=1; p=0.30). 
The last step of the statistical analysis was carried out using a non-parametric test due 
to low group sizes. For each disease group, Kruskal-Wallis one-way analysis of variance by 
ranks was used to compare HRV, WCC-R and MHLCS variables among healthy subjects, 
patients with positive and negative affective adjustment. Then, two by two comparisons were 
performed between healthy subjects, patients with negative and positive affective adjustment 
using Man-Whitney U tests. Lastly, comparisons were then made in-between pathologies 
(CD, UC and IBS), verifying the differences within patients presenting a solely positive affect 
or a solely negative affect. 
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3. Results 
3.1. Subject demographics 
Ninety-six Caucasians subjects were prospectively included. Patient and healthy subject 
demographics are detailed in Table 1. The number of patients under clinical relapse was as 
followed: (i) 5/26 CD patients; (ii) 6/22 UC patients and (iii) 6/27 IBS patients. 
3.2. Coping, health locus of control and HRV analysis according to 
positive and negative affective adjustment (Table 3) 
3.2.1. CD patients 
Differences among the groups were observed for problem-centred coping [H(2, 
N=47)=7.119240; p=0.028] and emotion-centred coping [H(2, N=47)=9.854478, p=0.007]. 
The CD+ patients presented higher problem-centred coping (p=0.02) and lower emotion-
centred coping (p=0.01) than the CD- patients. Moreover, the groups’ scoring varied on the 
“powerful others” external control scale [H(2, N=47)=11.13849; p =0.003] with both CD- (p= 
0.008) and CD+ (p= 0.04) sub-groups having higher external scores than the healthy subjects. 
No differences among the groups were observed for seeking social support, internal control 
and “chance” external control.  
The CD patients differed from the healthy subjects in LFn [H(2, N=47)=6.429656; p=0.040] 
and HFn [H(2, N=47)=8.504370; p=0.014] with CD+ patients having lower HFn (p=0.01) and 
higher LFn (p=0.003) levels than healthy ones. In contrast, there was no significant difference 
in LF/HF ratio, VLFn and HR among groups. No significant differences were found in any 
HRV variables between the CD+ and CD- patients. 
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3.2.2. UC patients 
Differences among the groups were observed for the following coping variables: problem 
coping [H(2, N=42)=7.349775; p=0.025]; emotion coping [H(2, N=42)=6.289190; p=0.043] 
with UC- patients exhibiting lower problem coping scores than UC+ patients (p=0.02) and 
higher emotion coping scores than healthy subjects (p=0.04). The three groups also expressed 
differences in the health locus of control on the internal scores [H(2, N= 42)=5.902678; 
p=0.05] and « powerful others » external scale [H(2, N=42)=8.654523; p =0.013] with UC- 
patients having lower scores on the internal scale (p=0.04) and higher scores on the “powerful 
others” external scale (p=0.03) than the healthy subjects. 
Differences among the groups were observed for HFn [H(2, N=43)=5.654144; p=0.05] 
with UC- exhibiting lower HFn level (p=0.05) than the healthy subjects. Although differences 
among the groups existed for VLFn [H(2, N=43)=6.422795; p=0.040], two by two 
comparisons were not statistically different. There was no difference in LF/HF ratio, LFn and 
HR among the 3 experimental groups. 
3.2.3. IBS patients 
Differences were observed among the groups for the three coping variables: problem-centred 
[H(2,N=48)=13.21082; p=0.001]; emotion-centred: H(2, N=48)=10.48181; p=0.005] and 
searching social support [H(2, N=48)=13.25554; p=0.001]. IBS- patients had lower problem 
coping scores than the healthy subjects (p=0.01) and IBS+ patients (p=0.003). They also 
exhibited higher emotion coping than the healthy subjects (p=0.003) and lower seeking social 
support coping compared to IBS+ patients (p=0.001). Interestingly, IBS+ patients used 
significantly more social support searching strategies than the healthy subjects (p=0.01). A 
tendency was also observed for group heterogeneity for the internal scale [H(2, 
N=46)=5.455534; p=0.065] and “chance” external scale [H(2, N=46)=5.878844; p=0.052]. 
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A difference among the groups was observed for LFn score [H (2, N=48)=15.02659; 
p<0.001], HFn [H(2, N=48)=19.32970; p<0.001] and LF/HF ratio [H(2, N=48)=14.70271; 
p<0.001], with IBS- patients having the highest LFn (p=0.001), the lowest HFn (p=0.0002) 
scores and obviously the highest LF/HF ratio (p=0.001) as compared to the healthy subjects. 
No difference was observed among the groups for VLFn and HR. 
3.3. In-between pathology comparisons 
When comparing only patients with positive affects, differences among pathologies were 
observed for social support searching [H (2, N= 36) =11.38878; p =0.003] with CD+ 
(p=0.003) and UC+ (p=0.04) patients having lower values than IBS+ patients. Differences 
among groups were also noticed on LH/HF ratio [H(2, N=37)=7.375762; p=0.025] and VLFn 
[H (2, N= 37)=7.307977; p=0.025]. Two by two comparisons showed that CD+ patients 
differed from UC+ patients on VLFn (p=0.02), while UC+ patients had lower LF/HF ratio than 
IBS+ patients (p=0.002). No differences were observed for other variables. 
When comparing all patients with negative affects, differences among pathologies 
were observed on “powerful others” external control [H(2, N=36)=7.463072; p=0.024] with 
CD- patients having a slightly higher score than IBS- patients (p=0.06). Differences among 
pathologies were also noticed for LFn [H(2, N= 38)=7.280014; p=0.026], HFn [H(2, 
N=38)=5.801725; p=0.055] and LF/HF ratio [H (2, N=38)=6.303644; p=0.042]. Two by two 
comparisons showed that CD- patients got lower LFn (p=0.02), higher HFn (p=0.04) and 
lower LF/HF ratio (p=0.03) than IBS- patients. No differences were observed for other 
variables. 
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4. Discussion 
The present study reveals that positive affective adjustment in patients with IBD (UC or CD) 
is associated to problem-focused coping strategies and adapted protective ANS activity. In 
IBS, the positive affective adjustment is also related to problem-focused coping strategies but 
ANS activity is not coupled to the psychological adjustment. 
4.1. Crohn’s disease patients 
The CD patients with positive affective adjustment (i.e., low scores of: anxiety, 
depressive symptomatology, negative mood and perceived stress) developed positive coping 
strategies since CD+ have a higher score in problem-focused coping and a lower score in 
emotion-focused coping than CD- patients. Concomitantly, CD+ exhibited a higher level of 
sympathetic activity and a lower level of parasympathetic activity than healthy subjects. Such 
an autonomic imbalance is not surprising since recent studies have revealed that the 
sympathetic nervous system may exert protective anti-inflammatory effects in CD (Stasi and 
Orlandelli, 2008; Straub et al., 2008). Moreover, nicotine, a parasympathetic agonist, is 
known to be deleterious in CD patients (Cosnes, 2004) as well as in an experimental model of 
CD (Galeazzi et al., 1999). Therefore our results indicate a coupling between positive coping 
strategy and an enhanced sympathetic activity in CD+ patients. Our results suggest that the 
interaction between perceived stress and avoidance coping recently reported in CD (Bitton et 
al., 2008) could be wider and would also involve a protective sympathetic adaptation of the 
sympatho-vagal balance. However, it should be outlined that ANS adaptation in positive 
coping represents a stress functioning with a higher biological cost explaining why CD 
patients generally report more anxiety and depression than UC patients (Nordin et al., 2002). 
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4.2. Ulcerative colitis patients 
The UC+ sub-group of patients also showed more focused-problem coping strategies than the 
UC- subgroup. This was coupled to an equilibrated autonomic balance although their VLFn 
was lower than that observed in the healthy subjects. Such a pattern might reflect a long-term 
parasympathetic vulnerability as VLF, principally influenced by the renin-angiotensin-
aldosterone system, this depends primarily on the presence of parasympathetic outflow. 
Indeed, the blockade of adrenergic receptors does not change VLF spectrum, whereas the 
blockade of nicotinic receptors abolishes it (Taylor et al., 1998). Conversely, the UC- patients 
showed a higher emotion-focused coping score. Their parasympathetic tonus was acutely 
blunted as suggested by the diminished HFn power spectral band compared to the healthy 
subjects. So, here again, the ANS activity is coupled to the way patients cope with their 
disease. However, three points should be highlighted: (i) The normal sympathetic activity in 
UC+ patients suggests that the ANS develops a reduced stress adaptation, with only a 
parasympathetic withdrawal, associated to positive coping and affective adjustment. 
Consequently, the biological cost for UC+ seems lower than that observed in CD+. This is 
supported by the fact that CD patients with increased disease activity report a greater impaired 
health-related quality of life and emotional distress than UC patients (Larsson et al., 2008). 
(ii) The lower ANS stress reaction in UC+ compared to UC- may reveal a higher 
parasympathetic tone bearing favourable activity. This is supported by the beneficial effect of 
nicotine in UC (Cosnes, 2004) and by data obtained from an animal model of UC (Ghia et al., 
2007). This agrees with theories on the physiological protective role of vagal tone (Porges, 
1995) and on the vagus cholinergic anti-inflammatory pathway (Pavlov and Tracey, 2005). 
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4.3. Irritable bowel syndrome patients  
As observed in IBD, IBS patients exhibited a coping behaviour in accordance with their 
emotional adjustment as IBS+ patients presented higher problem-focused coping and social 
support searching scores than IBS-. This agrees with the fact that IBS women based their 
coping more on social resources and less on personal resources (Fouché et al., 2006). 
Concomitantly, we observed profound disturbances in the sympatho-vagal balance in all IBS 
patients as compared to the healthy subjects. This is in accordance with other studies reporting 
a persistent sympathetic dominance in IBS patients at rest (Orr et al., 2000) and under stress 
(Tanaka et al., 2008) together with a persistent parasympathetic hyporeactivity (Van 
Orshoven et al., 2006) and a severe vagal dysfunction (Spaziani et al., 2008). The fact that we 
did not find any statistical differences in autonomic balance between IBS- and IBS+ patients 
could be due to a lack of statistical power linked to the small sample size. But this seems 
unlikely since we have found significant differences in IBD subgroups with similar sample 
sizes. Alternatively, the relative uncoupling of vagal tone with affective and coping behaviour 
merits discussion. IBS has been suggested to be mainly characterized by visceral 
hypersensitivity (Truong et al., 2008) and abnormal loci of brain activation to pain (Mayer et 
al., 2006; Mulak and Bonaz, 2004; Truong et al., 2008). The altered gut perception may 
induce false autonomic reflex responses to gut stimuli independently to the pathological status 
of the gut. Accordingly, in our study, diarrhoea-predominant IBS patients were equally 
dispatched in the IBS+ and IBS- subgroups and we did not find a correlation between affective 
adjustment and bowel habits as it was shown in other experimental conditions (Spetalen et al., 
2008).  
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4.4. Methodological considerations 
Comparisons among the diseases shed light on two main methodological points: (i) HRV 
analysis should not be isolated from the pathological mechanism (i.e., the pathology 
specificity) and the stress reaction, including psychobiological adjustment. In our sample, 
HRV parameters in CD and UC patients must be interpreted considering the negative or 
positive affects. Taken alone, HRV parameters may not provide a reliable conclusion about 
the nature of the adaptation of the autonomic balance. This aspect may explain contradictory 
results that could be found in the literature. Indeed, some studies found autonomic alterations 
only in UC and not in CD (Coruzzi et al., 2007; Ganguli et al., 2007), or in both (Mouzas et 
al., 2002) depending or not on the disease activity, quality of life or anxiety. Our results 
demonstrate further, that a set of negative affects (anxiety trait and state, negative mood, 
depressive symptomatology and perceived stress) with coping strategies influence the 
sympathetic/parasympathetic balance according to the specificities of each pathology. (ii) The 
behavioural adjustment observed in a given pathology is part of a more global adjustment 
corresponding to the equilibrium between the aggressor (i.e., the disease even if modulated by 
the environmental strain) and body changes due to coping. In our study, CD- had the highest 
score of “powerful others” external health locus of control while CD+ patients had the lowest 
score for searching social support. This result is in accordance with the fact that CD patients 
exhibit a higher external locus of control than patients with IBS or chronic idiopathic 
constipation (Hobbis et al., 2003). As a counterpart, this may reflect that CD is perceived by 
the individual as uncontrollable. The perception of control over the illness obviously depends 
on the pathology and its severity. In our groups, IBS patients exhibited the opposite pattern 
than those of CD patients, a result that agrees with another study showing an interaction 
between emotional distress and coping strategy in IBS patients (Rutter and Rutter, 2002). 
Studies taking into account disease controllability according to the type of intestinal 
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pathology are rare, although this concept is one of the most important in the transactional 
model of stress (Lazarus and Folkman, 1984). Even if IBD and IBS present different 
aetiology and pathophysiology, they share some common psychological features due to their 
chronicity, revealing that IBD and IBS are biopsychosocial models as currently stated for IBS 
(Camilleri, 2001; Mulak and Bonaz, 2004) and more recently proposed for IBD (Bitton et al., 
2008; Pigeon-Reesor and Ottawa, 2008). 
To conclude, this study suggests that the equilibrium of the ANS is differentially 
adapted according to the disease. This equilibrium is coupled with affective and cognitive 
positive adjustment in IBD but not in IBS. This raises the question of individual stress 
vulnerability in IBS or IBD patients. For a better understanding of the physiological, 
emotional and cognitive mechanisms of individual stress vulnerability, experimental and 
controlled-design studies are now required in this field. 
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Table 1. Subject demographics.  
 Healthy IBD 
                  CD                                        
UC 
IBS 
Total number of 
subjects 
21 26 22 27 
Mean age-yr (sem) 39±12 43±14 42±16 40±14 
Sex-M/F 8/13 8/18 9/13 9/18 
Mean duration of 
disease-yr (range) 
 14.2 (4-29) 10.7 (2-32) 9.1 (1-21) 
IBS 
     - Low abdominal pain   
(VAS<5/10) 
     - High abdominal  
pain (VAS>5/10) 
    
20 
 
7 
IBD 
Inactive disease 
- Mean HBI (range) 
- Mean Lichtiger’s 
score   (range) 
Active disease 
- Mean HBI (range) 
- Mean Lichtiger’s 
score   (range) 
  
21 
0.7 (0-4) 
 
 
5 
8 (6-11) 
 
16 
 
3.2 (1-7) 
 
6 
 
12.2 (11-13) 
 
Disease location 
Colitis 
Ileitis 
Ileo-colitis 
Pancolitis 
Left-sided colitis 
  
10 
8 
8 
 
 
 
 
 
6 
16 
 
Smoker (n)  4 1  
Treatment on inclusion: 
no. of patients (mean 
dose) 
- Mesalamine  
- Prednisone  
- Budesonide  
- Azathioprine/6-
MP  
- Methotrexate  
- Infliximab (each 8 
weeks) 
- Antispamodics 
- Antidiarrheic 
  
 
 
2 (2g) 
1 (30mg) 
1 (6mg) 
18 (150mg) 
 
3 (15mg) 
1 (5mg/kg iv) 
 
 
 
13 (2,5g) 
3 (30mg) 
 
6 (150mg) 
 
 
 
 
 
 
 
 
 
 
 
2 
2 
  
 
Table 2
 
. Descriptive variables (mean±sem) of the positive and negative affective adjustments in healthy subjects and patients, corresponding to 
the principle factor of affective adjustment. This factor includes several affective variables representative of anxiety, negative mood, depressive 
symptomatology and perceived stress. Patients presenting a low score on this principle factor are considered as positively adjusted and those with 
a high score are negatively adjusted (see Mat&Met for more precisions) 
 
 Healthy CD UC IBS 
  
N=21 
CD+ 
N=13 
CD- 
N=8 
UC+ 
N=13 
UC- 
N=9 
IBS+ 
N=10 
IBS- 
N=17 
STAI-trait 42.95±1.41 35.85±1.60 55.08±2.07 38.92±2.03 53.22±1.43 40.33±1.46 56.58±1.58 
STAI-state 33.76±2.21 30.50±1.39 48.41±3.44 31.30±1.71 52.77±3.30 32.40±2.06 47.94±2.86 
CES-D 8.57±1.19 7.71±1.22 25.58±2.89 12.30±2.17 23.88±2.63 8.60±1.40 26.88±2.87 
PANAS  20.80±1.81 19.42±1.50 29.83±1.41 19.61±1.06 30.44±2.62 21.90±1.10 30.35±1.92 
PSS 34.95±1.54 30.78±1.62 47.75±1.67 35.53±1.17 44.22±2.77 31.60±1.92 43.76±1.35 
 
Table 3. Physiological and psychological parameters in IBD and IBS patients (with positive and negative affects) and healthy subjects. Results 
are expressed as mean ± standard deviation. a significant differences between patients (CD, UC, IBS) with positive or negative affect and healthy 
subjects; b significant differences between subgroups of patients (positive versus negative); c significant differences in-between pathologies with 
positive affect; d significant differences in-between pathologies with negative affect. Statistical differences are detailed in the text. 
 
 Healthy Crohn’s Disease Ulcerative Colitis Irritable Bowel Syndrome 
  CD+ CD- UC+ UC- IBS+ IBS- 
WCC coping scores        
Problem-centred 31.5 ± 2.7 32.1±2.3 b 29.2±2.9 32.2±3.4 b 27.8±4.2 33.2±3.7 b 26.4±6.1 a 
emotion-centred 20.5 ± 3.6 20.2±3.9 b 24.9±3.9 a 20.5±5.3 24.4±1.4 a 22.1±3.1 24.7±3.7 a 
social support c 22.7 ± 3.2 21.7±3.5 21.3±5.2 23±3.98 21.1±4.4 27.5±3.2 a b 20.7±5 
Health Locus of control        
Internal scores 16.5 ± 2 15.4±1.8 15.8±1.8 16±2.5 14.5±1.6 a 16.7±2.5 15.3±2.6 
Powerful others scores d 11.7 ± 2.3 14.2±2.4 a 14.7±2.6 a 14±3.3 14.7±2.6 a 13.5±4.5 12.1±2.4 
Chance scores 13.4 ± 1.8 12.4±2.8 14.1±2.8 12±2.5 12.6±2.1 11.6±2.9 11.9±2.1 
Heart Rate Variability        
HR 69.9 ± 8.6 76.7±10.7 73.2±8.7 75.1±15.1 78±12.8 74.7±10 70±8.2 
LFn d 48 ± 10.9 59.2±12.4 a 52.1±10.8 47.6±18.1 59.08±12.6 64.6±17.2 a 65.2±14.1 a 
HFn d 48.1 ± 10.9 34.8±13.3 a 40±12.5 44.2±14.7 34.2±14.1 a 28.7±18.8 a 28.4±10.4 a 
LF/HF c d 1.2 ± 0.5 2.2±1.8 1.4±0.6 1.2±0.8 2.2±1.4 3.8±3.2 a 2.8±1.8 a 
VLFn c 0.9 ± 0.05 0.9±0.06 0.9±0.07 0.8±0.08 0.8±0.2 0.8±0.1 0.8±0.2 
 
 
 
